We use cookies on our website. Carry on browsing if you’re happy with this or find out more


Matthew McCourt

matthew mccourt

Matthew McCourt, Vice-President of Immuno-oncology, has been promoted internally, having joined Kymab in 2015. He brings 25 years’ experience in biopharmaceutical research and development.

His previous experience includes roles as Director of Oncology Biology at MedImmune, where his team drove the discovery and preclinical development of MedImmune’s immuno-oncology portfolio of biologics, and Head of Pharmacology at Cambridge Antibody Technology.